RESUMO

OBJECTIVE: To evaluate the clinical effect of sodium glycerophosphate (NaGP) in parenteral nutrition solutions on mineral metabolism in extremely low birth weight (ELBW) infants. STUDY DESIGN: NaGP was introduced for use in place of potassium phosphate (K3PO4) in January 2018; this retrospective cohort study included 95 ELBW infants treated with K3PO4 between January 2015 and December 2017 and 77 infants treated with NaGP between August 2018 and January 2021. Mineral intake over the first 14 days; changes in serum calcium, phosphorus, sodium, and alkaline phosphatase (ALP) levels over the first 1-3 months; and the rates of electrolyte imbalance and clinical morbidity were compared. High-risk infants who had nil per os (NPO) status for >14 days and prolonged parenteral nutrition exposure were further analyzed as a subgroup. RESULTS: The use of NaGP instead of K3PO4 significantly increased Ca and P intake, but intakes remained below the recommended range (Ca, 64-140 mg/kg/day; P, 50-108 mg/kg/day). Compared with levels in the K3PO4 group, the NaGP group had significantly higher serum Ca and P levels after day 14 and lower ALP levels after day 56. In the subgroup analysis, the NaGP group had significantly lower incidences of hypophosphatemia, hyponatremia, bronchopulmonary dysplasia, and ALP >500 IU/L. CONCLUSIONS: Although the administration of NaGP instead of K3PO4 in parenteral nutrition regimens still did not provide adequate Ca and P intake for ELBW infants, higher intake significantly improved serum Ca and P levels, especially in ELBW infants with prolonged parenteral nutrition exposure.

Assuntos

RESUMO

We evaluated the reliability of the oro-helical length in predicting the ideal endotracheal tube depth in neonates and found the oro-helical length was a consistently more reliable and better predictor of the ideal endotracheal tube depth on chest radiograph than the 7-8-9 rule, especially in infants weighing ≤1500 g.

Assuntos

RESUMO

Skin disinfection with chlorhexidine gluconate has not been standardized in preterm infants. We present 5 cases of chemical burns that occurred within the first 2 days of life in very low birth weight neonates after skin disinfection with aqueous and alcohol-based chlorhexidine solutions.

Assuntos

RESUMO

It has been reported in the 3 Benefits of Oxygen Saturation Targeting (BOOST-II) trials that changes in oximeter calibration software resulted in clearer separation between the oxygen saturations in the two trial target groups. A revised analysis of the published BOOST-II data does not support this conclusion.

Assuntos

RESUMO

Os limites de viabilidade na prematuridade e a sobrevivência com mínimo de sequela são temas atuais de grande importância ética. A prematuridade extrema pode resultar em inúmeras sequelas e danos crônicos que limitam a funcionalidade. Ao se optar pelo prolongamento da vida de recém-nascidos muito imaturos, há maior exposição do prematuro e da família a situações de dor, desconforto e estresse. A presente revisão trata dos aspectos éticos relacionados a essa tomada de decisão considerando o limite de viabilidade e as sequelas neuropsicomotoras decorrentes da prematuridade extrema. Atualmente, a questão gira em torno da importância da valorização não só da sobrevivência desses prematuros, mas também da manutenção de sua qualidade de vida, uma vez que são mais predispostos a sequelas em curto, médio e longo prazos...

Los límites de la viabilidad de la prematuridad y la supervivencia con secuelas mínimas son las principales cuestiones éticas de actualidad . La prematuridad extrema puede dar lugar a numerosas secuelas y daños crónicos que limitan la funcionalidad. Cuando se opta por la prolongación de la vida de los recién nacidos muy inmaduros, aumenta la exposición del prematuro y de la familia a situaciones de dolor, malestar y estrés. Esta revisión discute los temas éticos relacionados con esta toma de decisión teniendo en cuenta el límite de la viabilidad y las secuelas neuropsicomotoras como consecuencia de la prematuridad extrema. En la actualidad, la cuestión gira en torno a la importancia de valorar no sólo la supervivencia de los bebés prematuros, sino también el mantenimiento de su calidad de vida, ya que son más propensos a las secuelas en el corto, mediano y largo plazo...

Assuntos

RESUMO

OBJETIVO: Existem poucos relatórios publicados com relação à eficácia do ibuprofeno via oral no tratamento da persistência do canal arterial (PCA) em neonatos com extremo baixo peso ao nascer (EBPN). Comparamos o ibuprofeno via oral à indometacina intravenosa no que diz respeito à eficácia e segurança no tratamento de PCA em neonatos com peso inferior a 1.000 g ao nascer. MÉTODO: Este foi um estudo retrospectivo em um único centro. Coletamos dados de neonatos com EBPN que tiveram PCA ecocardiograficamente confirmada. Os neonatos foram tratados tanto com indometacina intravenosa quanto com ibuprofeno via oral. A taxa de fechamento do canal, a necessidade de tratamentos adicionais, os efeitos colaterais ou as complicações relacionadas ao medicamento e a mortalidade foram comparados entre os dois grupos de tratamento. RESULTADO: Examinamos 26 neonatos que receberam indometacina e 22 que receberam ibuprofeno. A taxa geral de fechamento do canal foi semelhante nos dois tratamentos: o fechamento do canal ocorreu em 23 dos 26 neonatos (88,5%) no grupo indometacina, e em 18 dos 22 neonatos (81,8%) no grupo ibuprofeno (p = 0,40). A taxa de ligadura cirúrgica (11,5% em comparação a 18,2%; p = 0,40) não diferiu de forma significativa entre os dois grupos de tratamento. Após o tratamento, não foi encontrada nenhuma diferença significativa nas concentrações de creatinina sérica entre os dois grupos. Não houve diferenças significativas com relação a efeitos colaterais ou complicações adicionais. CONCLUSÃO: Em neonatos com EBPN, o ibuprofeno via oral é tão eficaz quanto a indometacina intravenosa no tratamento da PCA. Não há diferenças entre os medicamentos no que diz respeito à segurança. O ibuprofeno via oral poderia ser usado como um agente alternativo no tratamento da PCA em neonatos com EBPN.

OBJECTIVE: There are few published reports concerning the efficacy of oral ibuprofen for the treatment of patent ductus arteriosus (PDA) in extremely low birth weight (ELBW) infants. Oral ibuprofen was compared to intravenous indomethacin regarding efficacy and safety in the treatment of PDA in infants weighting less than 1,000 g at birth. METHOD: This was a retrospective study in a single center. Data on ELBW infants who had an echocardiographically confirmed PDA were collected. The infants were treated with either intravenous indomethacin or oral ibuprofen. Rate of ductal closure, need for additional treatment, drug-related side effects or complications, and mortality were compared between the two treatment groups. RESULT: 26 infants who received indomethacin and 22 infants who received ibuprofen were studied. The overall rate of ductal closure was similar between the two treatments: it occurred in 23 of 26 infants (88.5%) treated with indomethacin, and in 18 of 22 infants (81.8%) treated with ibuprofen (p = 0.40). The rate of surgical ligation (11.5% versus 18.2%; p = 0.40) did not differ significantly between the two treatment groups. No significant difference was found in post-treatment serum creatinine concentrations between the two groups. There were no significant differences regarding additional side effects or complications. CONCLUSION: In ELBW infants, oral ibuprofen is as efficacious as intravenous indomethacin for the treatment of PDA. There were no differences between the two drugs with respect to safety. Oral ibuprofen could be used as an alternative agent for the treatment of PDA in ELBW infants.

Assuntos

RESUMO

Introduction. Perinatal mortality has significantly decreased over the last decades. Low birth weight and prematurity are amongst the strongest predictors of neonatal death. The main objective is to analyze the evolution of perinatal mortality and its causes in newborn infants with a birth weight of less than 1000 grams over the last 20 years (1991-2010). Population and Methods. Observational, descriptive, longitudinal and ecological study. A total of 264 infants weighing less than 1000 g out of a total of 56 024 births during the study period. Different specific perinatal mortality rates by weight were calculated. The Spearman's Rho correlation coefficient was applied to assess the relationship between mortality rates and years of study, and ANOVA and Mann-Whitney test were used to compare five-year periods and ten-year periods, respectively. Results. There were 131 perinatal deaths, 82 stillbirths and 49 early neonatal deaths; 64.1% of them occurred before 27 weeks of gestation. Only the fetal mortality rate was statistically significant, although perinatal mortality showed a downward trend, without reaching significance. The main immediate causes of death were extreme prematurity, intrauterine hypoxia and infection. The underlying causes related to death in this group of newborn infants were infection caused by premature rupture of membranes, maternal hypertension, uncontrollable preterm labor and twin pregnancy. Conclusions. The reduction in mortality rates in this group of newborn infants is undergoing a slowdown.

Introducción. La mortalidad perinatal ha disminuido sustancialmente en las últimas décadas. La prematuridad y el bajo peso al nacer son los factores predictivos más fuertemente asociados a esta mortalidad. El objetivo es analizar la evolución de la mortalidad perinatal en los nacidos con peso menor de 1000 g en los últimos 20 años (1991-2010) y sus causas. Población y métodos. Estudio observacional-descriptivo de tipo ecológico longitudinal, sobre 264 nacidos con peso menor de 1000 g de un total de 56 024 nacidos durante el período estudiado. Se calculan las diferentes tasas de mortalidad perinatal específicas por peso. Se aplica el coeficiente de correlación Rho de Spearman para evaluar la relación entre las tasas de mortalidad y los años de estudio, y las pruebas ANOVA y de Mann- Whitney para comparación de quinquenios y decenios, respectivamente. Resultados. Se han producido 131 muertes perinatales, 82 de ellas muertes fetales y 49 neonatales precoces. El 64,1% sucede antes de la semana de gestación 27. Sólo la tasa de mortalidad fetal presenta una disminución estadísticamente significativa, aunque la mortalidad perinatal presenta una tendencia al descenso, pero sin alcanzar la significación. Las principales causas inmediatas de óbito son la inmadurez extrema, la hipoxia intrauterina y la infección. Las causas fundamentales relacionadas con la muerte de este grupo de nacidos son la infección por rotura prematura de membranas, la hipertensión materna, la amenaza de parto pretérmino incontrolable y la gemelaridad. Conclusiones. La disminución de las tasas de mortalidad en este grupo de nacidos está sufriendo un enlentecimiento.

Assuntos

RESUMO

Introduction. Perinatal mortality has significantly decreased over the last decades. Low birth weight and prematurity are amongst the strongest predictors of neonatal death. The main objective is to analyze the evolution of perinatal mortality and its causes in newborn infants with a birth weight of less than 1000 grams over the last 20 years (1991-2010). Population and Methods. Observational, descriptive, longitudinal and ecological study. A total of 264 infants weighing less than 1000 g out of a total of 56 024 births during the study period. Different specific perinatal mortality rates by weight were calculated. The Spearmans Rho correlation coefficient was applied to assess the relationship between mortality rates and years of study, and ANOVA and Mann-Whitney test were used to compare five-year periods and ten-year periods, respectively. Results. There were 131 perinatal deaths, 82 stillbirths and 49 early neonatal deaths; 64.1% of them occurred before 27 weeks of gestation. Only the fetal mortality rate was statistically significant, although perinatal mortality showed a downward trend, without reaching significance. The main immediate causes of death were extreme prematurity, intrauterine hypoxia and infection. The underlying causes related to death in this group of newborn infants were infection caused by premature rupture of membranes, maternal hypertension, uncontrollable preterm labor and twin pregnancy. Conclusions. The reduction in mortality rates in this group of newborn infants is undergoing a slowdown.(AU)

Introducción. La mortalidad perinatal ha disminuido sustancialmente en las últimas décadas. La prematuridad y el bajo peso al nacer son los factores predictivos más fuertemente asociados a esta mortalidad. El objetivo es analizar la evolución de la mortalidad perinatal en los nacidos con peso menor de 1000 g en los últimos 20 años (1991-2010) y sus causas. Población y métodos. Estudio observacional-descriptivo de tipo ecológico longitudinal, sobre 264 nacidos con peso menor de 1000 g de un total de 56 024 nacidos durante el período estudiado. Se calculan las diferentes tasas de mortalidad perinatal específicas por peso. Se aplica el coeficiente de correlación Rho de Spearman para evaluar la relación entre las tasas de mortalidad y los años de estudio, y las pruebas ANOVA y de Mann- Whitney para comparación de quinquenios y decenios, respectivamente. Resultados. Se han producido 131 muertes perinatales, 82 de ellas muertes fetales y 49 neonatales precoces. El 64,1% sucede antes de la semana de gestación 27. Sólo la tasa de mortalidad fetal presenta una disminución estadísticamente significativa, aunque la mortalidad perinatal presenta una tendencia al descenso, pero sin alcanzar la significación. Las principales causas inmediatas de óbito son la inmadurez extrema, la hipoxia intrauterina y la infección. Las causas fundamentales relacionadas con la muerte de este grupo de nacidos son la infección por rotura prematura de membranas, la hipertensión materna, la amenaza de parto pretérmino incontrolable y la gemelaridad. Conclusiones. La disminución de las tasas de mortalidad en este grupo de nacidos está sufriendo un enlentecimiento.(AU)

Assuntos